Cargando…
Is human platelet lysate (hPL) the ideal candidate to substitute the foetal bovine serum for cell-therapy translational research?
Autores principales: | Guiotto, M., Riehle, M. O., Raffoul, W., Hart, A., di Summa, P. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513333/ https://www.ncbi.nlm.nih.gov/pubmed/34645479 http://dx.doi.org/10.1186/s12967-021-03104-w |
Ejemplares similares
-
Human platelet lysate to substitute fetal bovine serum in hMSC expansion for translational applications: a systematic review
por: Guiotto, M., et al.
Publicado: (2020) -
VP9: Human-Platelet Lysate Serum as a Potential Clinical-Translatable Supplement to Support Human Adipose-Derived Stem Cells Neurotrophic Properties
por: Guiotto, Martino, et al.
Publicado: (2022) -
Human Platelet Lysate Acts Synergistically With Laminin to Improve the Neurotrophic Effect of Human Adipose-Derived Stem Cells on Primary Neurons in vitro
por: Guiotto, Martino, et al.
Publicado: (2021) -
Human platelet lysate as a potential clinical-translatable supplement to support the neurotrophic properties of human adipose-derived stem cells
por: Palombella, Silvia, et al.
Publicado: (2020) -
hPL promotes osteogenic differentiation of stem cells in 3D scaffolds
por: Jafar, Hanan, et al.
Publicado: (2019)